GlaxoSmithKline PLC GLAXF:OTCPK

RT Quote | Exchange | USD
Last | 02/26/21 EST
16.53quote price arrow down-0.28 (-1.67%)
Volume
601,249
52 week range
14.96 - 22.00

...

Loading . . .

KEY STATS

  • Open17.26
  • Day High17.26
  • Day Low16.53
  • Prev Close16.81
  • 52 Week High22.00
  • 52 Week High Date04/27/20
  • 52 Week Low14.96
  • 52 Week Low Date03/23/20
  • Market Cap83,655.2M
  • Shares Out5,029.98M
  • 10 Day Average Volume874,111.09
  • Dividend-
  • Dividend Yield-
  • Beta0.56
  • 1 Year % Change-21.84

RATIOS/PROFITABILITY

  • EPS (TTM)1.58
  • P/E (TTM)10.46
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date04/28/2021
  • Ex Div Date02/18/2021
  • Div Amount23.00
  • Split Date-
  • Split Factor-

QUOTE FINDER

Related Video

VIDEO4:2904:29
Vir Biotech CEO on the expanded GSK partnership

Profile

MORE
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a...
Jonathan Symonds CBE
Non-Executive Chairman
Emma Walmsley
Chief Executive Officer
Iain Mackay
Chief Financial Officer
Address
G S K House, 980 Great West Road
Brentford
TW8 9GS
United Kingdom